Jeffrey G. Gaca
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jeffrey G. Gaca has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
James S. Gammie
University of Maryland School of Medicine, Baltimore, Maryland
3 shared publicationsPeter K. Smith
Department of Surgery, Duke University Medical Center, Durham, North Carolina
3 shared publications- Donald D. Glower
Division of Cardiothoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina
2 shared publications J. Scott Rankin
Vanderbilt University, Nashville, Tennessee
2 shared publications- Judson B. Williams
Department of Cardiovascular and Thoracic Surgery, WakeMed Health and Hospitals, Duke University School of Medicine, Raleigh, NC
2 shared publications Shubin Sheng
Duke Clinical Research Institute, Durham, North Carolina
2 shared publications
Latest Publications
- 27 October 2021
- Published by Springer Nature
- p. 119-129
Initial Medical Management of Acute Aortic Syndromes
- 27 October 2021
- Published by Springer Nature
- p. 119-129
Initial Medical Management of Acute Aortic Syndromes
- Open Access
- 1 September 2020
- Published by Elsevier in JTCVS Techniques
- Vol. 3, 198-201
Patch exclusion technique with Amplatzer septal occluder device for the treatment of postinfarction ventricular septal defect
- 1 September 2020
- Published by Elsevier in JTCVS Techniques
- Vol. 3, 198-201
Open AccessPatch exclusion technique with Amplatzer septal occluder device for the treatment of postinfarction ventricular septal defect
- 1 December 2019
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 108 (6) , 1613-1614
Acting In Good Faith: Operating Without Truly Informed Consent
- 1 December 2019
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 108 (6) , 1613-1614
Acting In Good Faith: Operating Without Truly Informed Consent
- 16 May 2019
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 108 (5) , 1325-1329
Impact of Microbiological Organism Type on Surgically Managed Endocarditis
- 16 May 2019
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 108 (5) , 1325-1329
Impact of Microbiological Organism Type on Surgically Managed Endocarditis
- 1 January 2019
- Published by Elsevier in Seminars in Thoracic and Cardiovascular Surgery
- Vol. 31 (3) , 381-382
The Mind Is Your Best Muscle: TAVR/SAVR Outcomes in Patients With Cognitive Impairment
- 1 January 2019
- Published by Elsevier in Seminars in Thoracic and Cardiovascular Surgery
- Vol. 31 (3) , 381-382
The Mind Is Your Best Muscle: TAVR/SAVR Outcomes in Patients With Cognitive Impairment
- 1 October 2016
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 102 (4) , 1046-1050
Can a Surgeon Refuse to Operate When an Advance Directive Limits Postoperative Care?
- 1 October 2016
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 102 (4) , 1046-1050
Can a Surgeon Refuse to Operate When an Advance Directive Limits Postoperative Care?
- 1 August 2015
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 29 (4) , 1071-1080
CASE 8—2015Paravertebral Catheter-Based Strategy for Primary Analgesia After Minimally Invasive Cardiac Surgery
- 1 August 2015
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 29 (4) , 1071-1080
CASE 8—2015Paravertebral Catheter-Based Strategy for Primary Analgesia After Minimally Invasive Cardiac Surgery
- 1 November 2013
- Vol. 22 (6) , 810-6
Risk-adjusted survival after tissue versus mechanical aortic valve replacement: a 23-year assessment.
Detailed analyses of risk-adjusted outcomes after mitral valve surgery have documented significant survival decrements with tissue valves at any age. Several recent studies of prosthetic aortic valve replacement (AVR) also have suggested a poorer performance of tissue valves, although analyses have been limited to small matched series. The study aim was to test the hypothesis that AVR with tissue valves is associated with a lower risk-adjusted survival, as compared to mechanical valves. Between 1986 and 2009, primary isolated AVR, with or without coronary artery bypass grafting (CABG), was performed with currently available valve types in 2148 patients (1108 tissue valves, 1040 mechanical). Patients were selected for tissue valves to be used primarily in the elderly. Baseline and operative characteristics were documented prospectively with a consistent variable set over the entire 23-year period. Follow up was obtained with mailed questionnaires, supplemented by National Death Index searches. The average time to death or follow up was seven years, and follow up for survival was 96.2% complete. Risk-adjusted survival characteristics for the two groups were evaluated using a Cox proportional hazards model with stepwise selection of candidate variables. Differences in baseline characteristics between groups were (tissue versus mechanical): median age 73 versus 61 years; non-elective surgery 32% versus 28%; CABG 45% versus 35%; median ejection fraction 55% versus 55%; renal failure 6% versus 1%; diabetes 18% versus 7% (p<0.01). Unadjusted Kaplan-Meier survival was significantly lower with tissue than mechanical valves; however, after risk adjustment for the adverse profiles of tissue valve patients, no significant difference was observed in survival after tissue or mechanical AVR. Thus, the hypothesis did not hold, and risk-adjusted survival was equivalent, of course qualified by the fact that selection bias was evident. With selection criteria that employed tissue AVR more frequently in elderly patients, tissue and mechanical valves achieved similar survival characteristics across the spectrum of patient risk. Further studies of the relative outcomes of mechanical versus tissue valves across the spectrum of patient age seem indicated.
- 1 November 2013
- Vol. 22 (6) , 810-6
Risk-adjusted survival after tissue versus mechanical aortic valve replacement: a 23-year assessment.
Detailed analyses of risk-adjusted outcomes after mitral valve surgery have documented significant survival decrements with tissue valves at any age. Several recent studies of prosthetic aortic valve replacement (AVR) also have suggested a poorer performance of tissue valves, although analyses have been limited to small matched series. The study aim was to test the hypothesis that AVR with tissue valves is associated with a lower risk-adjusted survival, as compared to mechanical valves. Between 1986 and 2009, primary isolated AVR, with or without coronary artery bypass grafting (CABG), was performed with currently available valve types in 2148 patients (1108 tissue valves, 1040 mechanical). Patients were selected for tissue valves to be used primarily in the elderly. Baseline and operative characteristics were documented prospectively with a consistent variable set over the entire 23-year period. Follow up was obtained with mailed questionnaires, supplemented by National Death Index searches. The average time to death or follow up was seven years, and follow up for survival was 96.2% complete. Risk-adjusted survival characteristics for the two groups were evaluated using a Cox proportional hazards model with stepwise selection of candidate variables. Differences in baseline characteristics between groups were (tissue versus mechanical): median age 73 versus 61 years; non-elective surgery 32% versus 28%; CABG 45% versus 35%; median ejection fraction 55% versus 55%; renal failure 6% versus 1%; diabetes 18% versus 7% (p<0.01). Unadjusted Kaplan-Meier survival was significantly lower with tissue than mechanical valves; however, after risk adjustment for the adverse profiles of tissue valve patients, no significant difference was observed in survival after tissue or mechanical AVR. Thus, the hypothesis did not hold, and risk-adjusted survival was equivalent, of course qualified by the fact that selection bias was evident. With selection criteria that employed tissue AVR more frequently in elderly patients, tissue and mechanical valves achieved similar survival characteristics across the spectrum of patient risk. Further studies of the relative outcomes of mechanical versus tissue valves across the spectrum of patient age seem indicated.
- 1 October 2013
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 96 (4) , 1374-1381
Current Outcomes for Tricuspid Valve Infective Endocarditis Surgery in North America
- 1 October 2013
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 96 (4) , 1374-1381
Current Outcomes for Tricuspid Valve Infective Endocarditis Surgery in North America
- 11 February 2013
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 145 (4) , 970-975
Twenty-five-year outcomes after multiple internal thoracic artery bypass
- 11 February 2013
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 145 (4) , 970-975
Twenty-five-year outcomes after multiple internal thoracic artery bypass